Work

Retraining and control therapy: sense of control and catastrophic symptom expectations as targets of a cognitive behavioral treatment for pediatric functional seizures

Year: 2026

Type: article

Abstract: This manuscript outlines the methodology of a randomized controlled trial (Clinical Registry #: NCT06007053) that aims to assess sense of control and catastrophic symptom expectations as targets of Retraining and Control Therapy (ReACT) a cognitive behavioral treatment for pediatric functional seizures (FS). Participants will complete baseline assessments of treatment targets and other outcome measures. The intervention will consist of either 12 sessions of ReACT or supportive therapy (i.e., unstructured, discussion-oriented therapy). Treatment targets and other outcome measures will be assessed again at one-week post-treatment and two-months post-treatment. The findings of the outlined study will contribute to the growing body of research on FS treatment by evaluating the effectiveness of ReACT in modifying key treatment targets and improving patient outcomes. If successful, ReACT may offer a structured, evidence-based approach for addressing FS in pediatric populations. Future directions include further refinement of the intervention and exploration of factors that may contribute to symptom persistence and remission. Clinical Trial Registration: https://clinicaltrials.gov/study/NCT05096273, identifier NCT05096273.

Source: Frontiers in Psychiatry

DOI: 10.3389/fpsyt.2025.1610446

Authors: Caroline Watson, Badhma Valaiyapathi, Jerzy P. Szaflarski, Burel R. Goodin, Aaron D. Fobian

Institutions: University of Alabama at Birmingham, Washington University in St. Louis

Language: English

Topic: Psychosomatic Disorders and Their Treatments

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,801